Lilly’s new drugs hold steady amid the pandemic, but one migraine launch lags esagonowsky Thu, 07/30/2020 – 11:38
Lilly, Boehringer—following AZ—nab Jardiance win in heart failure patients with or without diabetes kblankenship Thu, 07/30/2020 – 10:30
Roche’s Genentech cuts dozens of sales jobs in move to local healthcare ‘ecosystems’ esagonowsky Thu, 07/30/2020 – 08:56
Teva, Takeda offload generics, manufacturing plant to Nichi-Iko in Japanese venture reshuffle kblankenship Thu, 07/30/2020 – 08:48
AbstractObjectiveTo evaluate the performance of diagnostic prediction models for ovarian malignancy in all patients with an ovarian mass […]
AbstractObjectiveTo assess whether differences in income between male and female physicians vary according to the sex composition of […]
The monoclonal antibody is the first potential passive immunisation for infants to demonstrate sustained protection across the entire […]
Sales decline in the second quarter reflects expected disruption from COVID-19
NICE is not recommending NHS funding for Kyowa Kirin’s Poteligeo (mogamulizumab) as a treatment for mycosis fungoides or […]
